Survey of pharmacist knowledge, attitudes, and practices toward CGRP inhibitors for migraine management reveals education gaps and practice patterns in community pharmacy.
Key findingSurvey of pharmacist knowledge, attitudes, and practices toward CGRP inhibitors for migraine managem
What the researchers found
Survey of pharmacist knowledge, attitudes, and practices toward CGRP inhibitors for migraine management reveals education gaps and practice patterns in community pharmacy.
Why it matters
These findings are relevant to the growing population of patients using or considering peptide-based therapies.
The numbers in context
Cross-sectional survey of pharmacists in Saudi Arabia assessing knowledge, attitudes, and practices regarding CGRP inhibitors.
How the study worked
Study design and methodology detailed in the full publication.
Who was studied
Pharmacists in Saudi Arabia
What this study cannot tell us
Study limitations discussed in the full publication.
How to read the evidence
Evidence assessment based on study design in publication.
When this study was published
Published in 2025.
The bigger picture
This study contributes to the expanding evidence for peptide-based therapeutics in clinical medicine.
Questions still open
- What are the long-term implications?
- How do results compare to existing evidence?
- What further research is needed?
Common questions
What does this study mean for patients?
How reliable are these findings?
Read the original research
Pharmacists' Knowledge, Attitudes, and Practices Toward CGRP Inhibitors in Migraine Management: A Cross-Sectional Study.
Healthcare (Basel, Switzerland), 13(17)
Citation
Alfahmi, Anwar Seraj; Alqarni, Lana Abdullah; Alkhatabi, Lura Abdulrahman; Alshehri, Fahad S. (2025). Pharmacists' Knowledge, Attitudes, and Practices Toward CGRP Inhibitors in Migraine Management: A Cross-Sectional Study.. Healthcare (Basel, Switzerland), 13(17). https://doi.org/10.3390/healthcare13172231